UBS Initiates Genesis Healthcare With Neutral

UBS initiated coverage on

with a Neutral rating. The target price for Genesis Healthcare is set to $7. Genesis Healthcare shares have gained 1.24 percent over the past 52 weeks, while the S&P 500 index has surged 4.27 percent in the same period. Genesis Healthcare shares fell 2.97 percent to close at $6.53 yesterday.